Decrease in B-Type Natriuretic Peptide Levels and Successful Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure.

Autor:	YANAGISAWA, SATOSHI, INDEN, YASUYA, KATO, HIROYUKI, FUJII, AYA, MIZUTANI, YOSHIAKI, ITO, TADAHIRO, KAMIKUBO, YOSUKE, KANZAKI, YASUNORI, HIRAI, MAKOTO, MUROHARA, TOYOAKI
Předmět:	ATRIAL fibrillation treatment HEART failure treatment HEART ventricle diseases ACADEMIC medical centers BIOMARKERS CATHETER ablation CHI-squared test CONFIDENCE intervals FISHER exact test LEFT heart ventricle PEPTIDE hormones PROBABILITY theory STATISTICS T-test (Statistics) DISEASE relapse DATA analysis MULTIPLE regression analysis TREATMENT effectiveness PRE-tests & post-tests RETROSPECTIVE studies RECEIVER operating characteristic curves DESCRIPTIVE statistics ODDS ratio MANN Whitney U Test FRIEDMAN test (Statistics) VENTRICULAR ejection fraction THERAPEUTICS
Zdroj:	Pacing & Clinical Electrophysiology; Mar2016, Vol. 39 Issue 3, p225-234, 10p
Abstrakt:	Background Little is known about the association between B-type natriuretic peptide (BNP) levels and catheter ablation of atrial fibrillation (AF) in patients with heart failure. This study aimed to examine the impact of elimination of AF by catheter ablation on BNP levels in patients with left ventricular systolic dysfunction. Methods Fifty-four AF patients with left ventricular ejection fraction (LVEF) ≤ 50%, who underwent radiofrequency catheter ablation therapy of AF, were included. BNP sampling was performed at baseline, 3 days, and 1 month after ablation. Results After a follow-up period of 6 months, the BNP levels decreased significantly in the nonrecurrence group (n = 35; median 126.3 [interquartile 57.2-206.5] pg/mL, 63.5 [23.9-180.2] pg/mL, and 45.9 [21.9-160.3] pg/mL, P < 0.001, respectively), but not in the recurrence group (n = 19; 144.7 [87.1-217.3] pg/mL, 88.8 [12.9-213.2] pg/mL, and 118.5 [51.6-298.2] pg/mL, P = 0.368, respectively). The patients in the nonrecurrence group had a higher percentage relative reduction in BNP levels from baseline to 1 month after ablation than those in the recurrence group (56.5 [−9.0-77.4]% vs −2.4 [−47.1-60.9]%, P = 0.027). Additionally, a relative reduction in BNP levels significantly correlated with an increase in LVEF after ablation (r = 0.486, P < 0.001). Conclusions Plasma BNP levels decreased significantly with successful catheter ablation of AF in patients with impaired LVEF. The decrease in BNP levels might be associated with early recovery of cardiac function and subsequent maintenance of sinus rhythm at follow-up. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.